Combining brain imaging with microarray: isolating molecules underlying the physiologic disorders of the brain.

Area of Science:

• Neuroscience
• Molecular Biology
• Medical Imaging

Background:

• Many nervous system diseases impair neuronal physiology rather than brain anatomy.
• This physiological disruption, seen in conditions like Alzheimer's disease and psychiatric disorders, lacks clear anatomical markers.
• The absence of anatomical markers hinders the identification of targeted cells and pathogenic molecules.

Purpose of the Study:

• To demonstrate how brain imaging and microarray analysis can be used complementarily.
• To characterize the cellular and molecular aspects of diseases primarily affecting neuronal physiology.
• To overcome the limitations posed by the lack of clear anatomical markers in diagnosing and treating these neurological conditions.

Main Methods:

• Utilizing advanced brain imaging techniques to assess physiological function.
• Employing microarray analysis to study gene expression profiles at the cellular level.
• Integrating data from imaging and molecular analyses to provide a comprehensive disease characterization.

Main Results:

• Successfully characterized cellular and molecular aspects of diseases with subtle anatomical changes.
• Established a combined imaging and microarray approach for identifying pathogenic mechanisms.
• Provided a framework for understanding and targeting diseases based on physiological dysfunction.

Conclusions:

• Brain imaging and microarray analysis are powerful complementary tools for studying neurological diseases.
• This integrated approach can identify cellular and molecular targets in conditions lacking clear anatomical pathology.
• The findings pave the way for improved diagnostics and therapeutics for a range of neurological disorders.